Tolerability Study of Liquid Metformin (100 and 250 mg/mL) vs IR Tablets

This is an open-label, randomized study evaluating the tolerability of two concentrations of liquid metformin formulations (100 mg/mL and 250 mg/mL) compared with standard immediate-release metformin tablets in healthy adult subjects. Each participant will receive single oral doses of study treatments in a randomized sequence. Safety and tolerability will be assessed through adverse event monitoring, gastrointestinal symptom evaluations, vital signs, clinical laboratory tests, and ECGs.

NCT Number	NCT07300046
Lead Sponsor	Aspargo Labs, Inc
Conditions	Healthy Volunteers
Enrollment	24 participants
Start Date	2026-06-15
Primary Completion	2026-08-15 (estimated)
Study Completion	2026-08-28 (estimated)
Updated on ClinicalTrials.gov	2025-12-23